E-LIB Suche - Ergebnisse für: Herranz Pinto, Pedro Francisco

1

Real-world Performance of a New Strategy for Off-Label Use ..:

Herranz Pinto, Pedro Francisco ; Alonso Pacheco, Maria Luisa ; Feltes Ochoa, Rosa...
Clinical Drug Investigation. , 2023

Link: http://hdl.handle.net/10..

2

Prevalencia y factores de riesgo de la neoplasia intraepite..:

Herranz Pinto, Pedro Francisco
http://hdl.handle.net/10486/9853. , 2014

Link: http://hdl.handle.net/10..

3

Cost-Effectiveness Analysis of Abrocitinib Compared with Ot..:

Romero Jiménez, Rosa María ; Herranz Pinto, Pedro ; Campos Domínguez, Minia...
PharmacoEconomics - Open. 8 (2024) 2 - p. 291-302 , 2024

Link: https://doi.org/10.1007/..

4

The social value of a PASI 90 or PASI 100 response in patie..:

Maravilla-Herrera, Paulina ; Merino, María ; Alfonso Zamora, Santiago...
Frontiers in Public Health. 11 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Unmet Needs in the Management of Moderate-to-Severe Psorias..:

Zozaya, Néboa ; Villoro, Renata ; Abdalla, Fernando...
Acta Dermato-Venereologica. 102 (2022) - p. adv00678 , 2022

Link: https://doi.org/10.2340/..

6

Assessing the value contribution of bimekizumab for the tre..:

Zozaya, Néboa ; Abdalla, Fernando ; Alfonso Zamora, Santiago...
Expert Review of Pharmacoeconomics & Outcomes Research. 22 (2022) 6 - p. 941-953 , 2022

Link: https://doi.org/10.1080/..

7

Pathologically Confirmed Malignant Syphilis Using Immunohis..:

Cid, Paola Maldonado ; Cudós, Elena Sendagorta ; Vargas, Francisco X. Zamora..
Sexually Transmitted Diseases. 41 (2014) 2 - p. 94-97 , 2014

Link: https://www.jstor.org/st..

8

The social value of a PASI 90 or PASI 100 response in patie..:

Maravilla-Herrera, Paulina ; Merino, María ; Alfonso Zamora, Santiago...
Frontiers in Public Health. , 2023

Link: https://ddd.uab.cat/reco..

9

The social value of a PASI 90 or PASI 100 response in patie..:

Maravilla-Herrera, Paulina ; Merino, María ; Alfonso Zamora, Santiago...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909187/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Unmet Needs in the Management of Moderate-to-Severe Psorias..:

Zozaya, Néboa ; Villoro, Renata ; Abdalla, Fernando...
http://hdl.handle.net/10668/20502. , 2022

Link: http://hdl.handle.net/10..

11

Unmet Needs in the Management of Moderate-to-Severe Psorias..:

Zozaya, Néboa ; Villoro, Renata ; Abdalla, Fernando...
http://hdl.handle.net/10668/20502. , 2022

Link: http://hdl.handle.net/10..

12

Unmet Needs in the Management of Moderate-to-Severe Psorias..:

ZOZAYA, Néboa ; VILLORO, Renata ; ABDALLA, Fernando...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631248/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Assessing the value contribution of bimekizumab for the tre..:

Zozaya, Néboa ; Abdalla, Fernando ; Alfonso Zamora, Santiago...
http://hdl.handle.net/10668/19680. , 2022

Link: http://hdl.handle.net/10..

14

The social value of a PASI 90 or PASI 100 response in patie..:

Paulina Maravilla-Herrera ; María Merino ; Santiago Alfonso Zamora...
https://www.frontiersin.org/articles/10.3389/fpubh.2023.1000776/full. , 2023

Link: https://doi.org/10.3389/..

15

Unmet Needs in the Management of Moderate-to-Severe Psorias..:

Néboa Zozaya ; Renata Villoro ; Fernando Abdalla...
https://medicaljournalssweden.se/actadv/article/view/583. , 2022

Link: https://doi.org/10.2340/..